Title: A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naïve patients with type 2 diabetes.
Authors: Hae Kyung Yang; Kyung Wan Min; Sung Woo Park; Choon Hee Chung; Kyong Soo Park; Sung Hee Choi; Ki-Ho Song; Doo-Man Kim; Moon-Kyu Lee; Yeon-Ah Sung; Sei Hyun Baik; In Joo Kim; Bong-Soo Cha; Jeong Hyun Park; Yu Bae Ahn; In-Kyu Lee; Soon Jib Yoo; Jaetaek Kim; Ie Byung Park; Tae Sun Park
Publication: Endocrine Journal, 2015, Vol 62, Issue 5, p449
ISSN: 0918-8959
Publication type: Academic Journal
DOI: 10.1507/endocrj.ej14-0544

A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naïve patients with type 2 diabetes.

Hae Kyung Yang; Kyung Wan Min; Sung Woo Park; Choon Hee Chung; Kyong Soo Park; Sung Hee Choi; Ki-Ho Song; Doo-Man Kim; Moon-Kyu Lee; Yeon-Ah Sung; Sei Hyun Baik; In Joo Kim; Bong-Soo Cha; Jeong Hyun Park; Yu Bae Ahn; In-Kyu Lee; Soon Jib Yoo; Jaetaek Kim; Ie Byung Park; Tae Sun Park